Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- 4 of 10 Listed Wholesalers Report Losses
June 11, 2001
- Korosho Official Explains Criteria for Disclosure or Non-disclosure
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -5-
June 11, 2001
- Japan-EU Mutual GMP Recognition Treaty Approved by Lower House
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -6-
June 11, 2001
- REGULATORY NEWS IN BRIEF -1-
June 11, 2001
- AstraZeneca Introduces Mentoring System
June 11, 2001
- REGULATORY NEWS IN BRIEF -2-
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -7-
June 11, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 11, 2001
- Sysmex: Sales Down in US, Japan, but Up in Europe, Asia
June 11, 2001
- 2% Price Adjustment Range Needs Urgent Review: FJPWA
June 11, 2001
- Olympus: Good Sales of Medical Endoscopes Overseas Drive Sales, Profits
June 11, 2001
- Nippon BD Ties Up with TAUNS Regarding Infectious Disease Diagnosis Kits
June 11, 2001
- Richfield to Embark on MR Dispatching Business
June 11, 2001
- Olympus: New Endoscope Position Detective Unit
June 11, 2001
- Matsumotokiyoshi: Sales Up 1% but Operating Profits Down 0.9%
June 11, 2001
- Tokyo Women's Medical Univ. Introduces "MR-kun"
June 11, 2001
- Genzyme Aims at Leading Biosurgery Market
June 11, 2001
- New Quasi-drug Sales Up 8.5%, to \155.3 Bil.
June 11, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…